Across TCGA pan-cancer cohorts, RNY3P12 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNY3P12’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNY3P12 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNY3P12 is over-expressed in tumor.

BRCA and KIRC are the cancer types where RNY3P12 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNY3P12 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.199	.023	2	view →
KIRC	All	All	+0.056	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNY3P12 RNA expression & survival · all RNY3P12 data types